The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Andrew Berchuck

Department of Obstetrics and Gynecology

Division of Gynecologic Oncology

Institute for Genome Sciences and Policy

Duke University Medical Center

USA

[email]@mc.duke.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Institute for Genome Sciences and Policy, Duke University Medical Center, USA. 2004 - 2009

References

  1. Microarray analysis of early stage serous ovarian cancers shows profiles predictive of favorable outcome. Berchuck, A., Iversen, E.S., Luo, J., Clarke, J.P., Horne, H., Levine, D.A., Boyd, J., Alonso, M.A., Secord, A.A., Bernardini, M.Q., Barnett, J.C., Boren, T., Murphy, S.K., Dressman, H.K., Marks, J.R., Lancaster, J.M. Clin. Cancer Res. (2009) [Pubmed]
  2. Role of genetic polymorphisms in ovarian cancer susceptibility: development of an international ovarian cancer association consortium. Berchuck, A., Schildkraut, J.M., Pearce, C.L., Chenevix-Trench, G., Pharoah, P.D. Adv. Exp. Med. Biol. (2008) [Pubmed]
  3. Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers. Berchuck, A., Iversen, E.S., Lancaster, J.M., Pittman, J., Luo, J., Lee, P., Murphy, S., Dressman, H.K., Febbo, P.G., West, M., Nevins, J.R., Marks, J.R. Clin. Cancer Res. (2005) [Pubmed]
  4. Prediction of optimal versus suboptimal cytoreduction of advanced-stage serous ovarian cancer with the use of microarrays. Berchuck, A., Iversen, E.S., Lancaster, J.M., Dressman, H.K., West, M., Nevins, J.R., Marks, J.R. Am. J. Obstet. Gynecol. (2004) [Pubmed]
  5. Progesterone receptor promoter +331A polymorphism is associated with a reduced risk of endometrioid and clear cell ovarian cancers. Berchuck, A., Schildkraut, J.M., Wenham, R.M., Calingaert, B., Ali, S., Henriott, A., Halabi, S., Rodriguez, G.C., Gertig, D., Purdie, D.M., Kelemen, L., Spurdle, A.B., Marks, J., Chenevix-Trench, G. Cancer Epidemiol. Biomarkers Prev. (2004) [Pubmed]
 
WikiGenes - Universities